The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 12, 2019

Filed:

Oct. 06, 2014
Applicant:

Universitetet I Oslo, Oslo, NO;

Inventors:

Pål Rongved, Oslo, NO;

Ove Alexander Høgmoen Åstrand, Oslo, NO;

Annette Bayer, Tromsø, NO;

Hanna-Kirsti Schrøder Leiros, Tromsø, NO;

Ørjan Samuelsen, Tromsø, NO;

Kine Susann Waade Edvardsen, Paradis, NO;

Zeeshan Muhammad, Tromsø, NO;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 45/06 (2006.01); A61P 31/04 (2006.01); C07D 401/14 (2006.01); A61K 31/444 (2006.01); A61K 38/05 (2006.01); C07D 405/14 (2006.01); C07K 5/062 (2006.01); A61K 47/64 (2017.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); A61K 31/444 (2013.01); A61K 38/05 (2013.01); A61K 45/06 (2013.01); A61K 47/64 (2017.08); C07D 405/14 (2013.01); C07K 5/06026 (2013.01);
Abstract

Compounds according to formula I are provided:A-L-Bwherein A represents a lipophilic chelating moiety which is selective for Znions; L is a covalent bond or a linker; and B is a vector which is either a moiety capable of interacting with one or more biological structures found in a bacterium (preferably in a bacterial cell wall), for example a penicillin-binding protein such as a metallo-β-lactamase or DD-transferase, or a moiety capable of enhancing transport of the compound across a bacterial cell membrane. A method of treating and/or preventing a bacterial infection in a human or non-human mammal employing such compounds are also provided. In such a method, the compound of formula I may be administered in combination with (either simultaneously, separately, or sequentially) a β-lactam antibiotic.


Find Patent Forward Citations

Loading…